Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis

Effect of the multifunctional proteins RPA, YB-1, and XPC repair factor on AP site cleavage by DNA glycosylase NEIL1

(2012) Pavel Pestryakov et al.   JOURNAL OF MOLECULAR RECOGNITION

An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells

(2011) Chantal Garand et al.   CANCER SCIENCE

Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

(2011) Gordon John Sampson Rustin et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Prognostic Association of YB-1 Expression in Breast Cancers: A Matter of Antibody

(2011) Adele G. Woolley et al.   PLoS One

Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer

(2010) Tomomi Egawa-Takata et al.   CANCER SCIENCE

Pharmacogenomics of Taxane/Platinum Therapy in Ovarian Cancer

(2010) Sharon Marsh   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Identification of a Cytoplasmic Complex That Adds a Cap onto 5'-Monophosphate RNA

(2009) Y. Otsuka et al.   MOLECULAR AND CELLULAR BIOLOGY

BTF4/BTNA3.2 and GCS as Candidate mRNA Prognostic Markers in Epithelial Ovarian Cancer

(2008) C. Le Page et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells

(2008) David Guay et al.   CANCER SCIENCE

The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma

(2007) M. Chatterjee et al.   BLOOD